Corticosteroid
Patients with severe eosinophilic asthma, prior biologic use benefit from benralizumab
Among adults with severe eosinophilic asthma and previous biologic use, benralizumab for 48 weeks aided in reducing exacerbations and improving asthma symptom control, according to results published in European Respiratory Journal.
Fewer than 50% of patients with sarcoidosis treated within year of diagnosis
Less than half of patients with sarcoidosis had been treated by the 1-year mark since being diagnosed with the condition, according to results published in CHEST.
New inhaled COPD maintenance medication prescriptions rise in recent years
BOSTON — Compared with 17,800 patients starting new inhaled COPD maintenance therapy in 2016, 32,558 patients started a new inhaled treatment in 2022, according to a presentation at the CHEST Annual Meeting.
Maintaining asthma control lessens risk for asthma complications in pregnant patients
BOSTON — Asthma control during pregnancy lowers the risk for complications, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Concomitant use of common medications does not significantly affect UC induction therapy
Baseline concomitant exposure to commonly used medications, such as corticosteroids and 5-aminosalicylates, did not significantly affect clinical and endoscopic outcomes during induction therapy in ulcerative colitis, data analysis showed.
At 4 years since COPD diagnosis, patients without treatment common
When diagnosed with COPD, 86.2% of patients did not receive treatment, and after 4 years, 63.8% still had not been treated, according to results published in BMC Pulmonary Medicine.
Triamcinolone, methylprednisolone avoid prednisone’s fracture risk ‘trap’ in lupus
WASHINGTON — Although even low-dose prednisone significantly increases the risk for fracture in systemic lupus erythematosus, there is no increased risk from intramuscular triamcinolone or intravenous methylprednisolone, said a speaker.
Older age, multiple comorbidities frequent in patients starting inhaled COPD therapy
BOSTON — Among adults with COPD starting a new inhaled maintenance treatment, common characteristics included older age and having multiple comorbidities, according to a poster presented at the CHEST Annual Meeting.
54% of pediatric asthma caregivers familiar with oral corticosteroid long-term effects
BOSTON — Among caregivers of children with asthma, only 54% were familiar with oral corticosteroid long-term side effects, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Adalimumab slashes Behçet’s uveitis relapse rate significantly more than cyclosporine
Adalimumab combined with corticosteroids led to a significantly lower rate of relapse in Behçet’s disease uveitis vs. cyclosporine alongside corticosteroids, according to data published in The Lancet Rheumatology.